Consolidated Statements of Changes in Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands |
Total |
Common Stock |
Additional Paid-in Capital |
Retained Earnings |
Accumulated Other Comprehensive Loss |
Treasury Stock |
| Balance, at start of period (in shares) at Feb. 01, 2020 |
|
63,922
|
|
|
|
|
| Balance, at start of period at Feb. 01, 2020 |
$ 406,302
|
$ 936
|
$ 215,207
|
$ 533,690
|
$ 0
|
$ (343,531)
|
| Balance, at start of period, treasury stock (in shares) at Feb. 01, 2020 |
|
|
|
|
|
29,710
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Net loss |
(405,449)
|
|
|
(405,449)
|
|
|
| Exercise of stock options and restricted stock (in shares) |
|
1,392
|
|
|
|
(1,392)
|
| Exercise of stock options and restricted stock |
0
|
|
(2,528)
|
(13,509)
|
|
$ 16,037
|
| Share-based compensation |
$ 9,462
|
|
9,462
|
|
|
|
| Repurchase of common stock (in shares) |
0
|
343
|
|
|
|
343
|
| Repurchase of common stock |
$ (626)
|
|
|
|
|
$ (626)
|
| Balance, at end of period (in shares) at Jan. 30, 2021 |
|
64,971
|
|
|
|
|
| Balance, at end of period at Jan. 30, 2021 |
9,689
|
$ 936
|
222,141
|
114,732
|
0
|
$ (328,120)
|
| Balance, at end of period, treasury stock (in shares) at Jan. 30, 2021 |
|
|
|
|
|
28,661
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Net loss |
(14,436)
|
|
|
(14,436)
|
|
|
| Exercise of stock options and restricted stock (in shares) |
|
3,084
|
|
|
|
(3,084)
|
| Exercise of stock options and restricted stock |
0
|
|
(11,872)
|
(23,203)
|
|
$ 35,075
|
| Share-based compensation |
$ 9,809
|
|
9,809
|
|
|
|
| Repurchase of common stock (in shares) |
0
|
983
|
|
|
|
983
|
| Repurchase of common stock |
$ (3,754)
|
|
|
|
|
$ (3,754)
|
| Balance, at end of period (in shares) at Jan. 29, 2022 |
67,072
|
67,072
|
|
|
|
|
| Balance, at end of period at Jan. 29, 2022 |
$ 1,308
|
$ 936
|
220,078
|
77,093
|
0
|
$ (296,799)
|
| Balance, at end of period, treasury stock (in shares) at Jan. 29, 2022 |
26,560
|
|
|
|
|
26,560
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Net loss |
$ 293,834
|
|
|
293,834
|
|
|
| Issuance of common stock (in shares) |
|
5,435
|
|
|
|
|
| Issuance of common stock |
6,899
|
$ 54
|
6,845
|
|
|
|
| Exercise of stock options and restricted stock (in shares) |
|
1,888
|
|
|
|
(1,888)
|
| Exercise of stock options and restricted stock |
0
|
|
(5,830)
|
(15,191)
|
|
$ 21,021
|
| Share-based compensation |
$ 7,540
|
|
7,540
|
|
|
|
| Repurchase of common stock (in shares) |
0
|
635
|
|
|
|
635
|
| Repurchase of common stock |
$ (2,012)
|
|
|
|
|
$ (2,012)
|
| Balance, at end of period (in shares) at Jan. 28, 2023 |
73,760
|
73,760
|
|
|
|
|
| Balance, at end of period at Jan. 28, 2023 |
$ 307,569
|
$ 990
|
$ 228,633
|
$ 355,736
|
$ 0
|
$ (277,790)
|
| Balance, at end of period, treasury stock (in shares) at Jan. 28, 2023 |
25,307
|
|
|
|
|
25,307
|